TRVI
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Trevi Therapeutics completed an end-of-Phase 2 meeting with the FDA supporting its development plan for chronic cough in idiopathic pulmonary fibrosisMar 9, 2026
- Trevi Therapeutics announces two posters from the Phase 2a RIVER trial data will be featured at the European Respiratory Society Congress 2025Sep 18, 2025
- Trevi Therapeutics announces positive topline results from Phase 2b CORAL trial of Haduvio in patients with idiopathic pulmonary fibrosis chronic coughJun 2, 2025
- Trevi Therapeutics reports additional analyses from Phase 2a RIVER trial of Haduvio in patients with refractory chronic cough.May 20, 2025
- Trevi Therapeutics to host conference call and webcast on March 10 to share topline results from Phase 2a RIVER Trial of Haduvio in refractory chronic cough patientsMar 11, 2025